Patents
Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
08/2003
08/07/2003WO2003064439A2 Sialic carbohydrates
08/06/2003EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/06/2003CN1117057C Cyclopentenones, process for preparing same, and use thereof
07/2003
07/31/2003US20030144543 Microwave irradiation process for preparing methyl esters
07/30/2003EP1330465A2 Derivatised carbohydrates and their use in solid delivery systems
07/24/2003WO2003059866A1 Geranyl compounds
07/24/2003CA2706833A1 Geranyl compounds
07/24/2003CA2706826A1 Geranyl compounds
07/16/2003CN1114410C Product of heat treatment of uronic acid, food, drink and drug containing the product
07/08/2003US6590121 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
07/08/2003US6590110 Reacting halogenated ulosonic acid with aldehyde or ketone compound in presence of lanthanide metal halide
06/2003
06/26/2003US20030119758 An amine salt of (1-O-(4-(3,4-dimethoxyphenyl)-2-(3-ethylpentanoyl)-5,6,7-trimethoxy-3 -(methoxycarbonyl)naphthalen - 1-yl)-beta-D-glucopyranoside)uronic acid.
06/25/2003EP1169313B1 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
06/24/2003US6583297 Process and intermediate compounds for the preparation of pyrrolidines
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003US20030109710 Viricides, Aids, herpes virus
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/03/2003US6573400 Preparation of 2-keto-L-gulonic esters
06/03/2003US6573248 Monocyclic L-nucleosides, analogs and uses thereof
05/2003
05/27/2003US6569649 Compositions and methods for saccharide synthesis
05/21/2003EP1091970B1 Method for preparing aloin by extraction
05/20/2003US6566015 Non-aqueous electrolytic salt and non-aqueous electrolytic secondary battery in which it is used
05/14/2003EP1310505A1 Amine salt of lignan compound
05/13/2003US6562791 Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
05/06/2003CA2157937C Method and apparatus for manufacturing monocarboxylic acids from carbohydrates, carbohydrate derivatives or primary alcohols
05/02/2003EP1306443A1 Esters of uronic acids
05/02/2003EP1305284A1 Process and intermediate compounds for the preparation of pyrrolidines
05/01/2003WO2003035661A1 Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
05/01/2003CA2464311A1 Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
04/2003
04/30/2003CN1414004A Method for preparing 1,2,5,6-bi-isopropyl lidene glucofuranose
04/29/2003US6555698 A 3-(enzymatically cleavable 2-n-acetylneuraminic acid)spiro 1,2-dioxacyclobutane compound, e.g. spiro(adamantane-3,3'-1,2 -dioxabutane; diagnosis for the influenza virus, respiratory system infections; sensitivity;
04/23/2003EP1027359B1 Monocyclic l-nucleosides, analogs and uses thereof
04/22/2003US6552184 Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique
04/22/2003US6552183 Moncyclic L-nucleosides analogs
04/17/2003US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
04/15/2003US6548484 An amidation product of ribosyl or glucosyl saccharide and a dopamine or derivative ( forms a amide through amine and carboxylic group); useful for treating neurological diseases including Parkinson's and related diseases
04/10/2003WO2003000709A9 Sialic acid derivatives for use as siglec inhibitors
04/09/2003EP1300412A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same
04/09/2003EP1300411A1 Novel disaccharides with anti-arthritic action
04/04/2003WO2002030940A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
04/04/2003CA2424926A1 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
04/03/2003US20030064935 Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
04/02/2003CN1407990A C-aryl glucoside sgltz inhibitors
04/02/2003CN1406945A Preparation of 1,2;5,6-diisopropylidene galactofructofuranose
04/01/2003US6541228 Electrodialysis methods for purification and recovery of gluconic acid derivatives
03/2003
03/26/2003EP0841931B1 Pharmaceutical composition
03/20/2003WO2003022860A1 Synthetic heparin pentasaccharides
03/20/2003CA2806723A1 Synthetic heparin pentasaccharides
03/20/2003CA2806604A1 Synthetic heparin pentasaccharides
03/20/2003CA2806561A1 Synthetic heparin pentasaccharides
03/18/2003US6534637 Synthesis of chlorophenol red glucuronic acid
03/18/2003US6534481 Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin
03/13/2003WO2002072593A3 Alkylated c-sugars and uses thereof
03/13/2003US20030050257 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
03/12/2003EP1291018A1 Pharmaceutical composition
03/06/2003WO2003018598A2 Monosaccharide derivatives
03/06/2003WO2002083066A3 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
03/04/2003US6528494 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
02/2003
02/27/2003WO2002064605A3 Synthesis of chlorophenol red glucoronic acid
02/13/2003WO2003011881A2 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
02/13/2003WO2002062810A3 Linkable sialyl lewis x analogs
02/11/2003US6518437 Process and intermediate compounds for the preparation of pyrrolidines
02/11/2003US6518419 Process for selective oxidation of primary alcohols
02/04/2003US6515117 C-aryl glucoside SGLT2 inhibitors and method
01/2003
01/28/2003US6512100 Chromogenic substrates of sialidase and methods of making and using the same
01/28/2003US6511965 Ether type lipid A 1-carboxylic acid analogs
01/28/2003CA2253654C Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor
01/23/2003US20030018186 Monocyclic L-nucleosides, analogs and uses thereof
01/16/2003US20030010254 Cements, raw materials for cements as for admixing with mortars, slurries and concretes
01/14/2003US6506387 Method for preparing aloin by extraction
01/09/2003WO2003002127A1 Use of at least one glycoinhibitor substance
01/08/2003EP1272176A1 Adamantyl derivatives as anti-cancer agents
01/03/2003WO2003000709A2 Sialic acid derivatives for use as siglec inhibitors
01/03/2003WO2002051828A3 Novel c-glycoside derivatives and use thereof
12/2002
12/27/2002WO2002051803A3 Novel c-glycoside derivatives and use thereof
12/24/2002US6498269 Method for the oxidation of aldehydes, hemiacetals and primary alcohols
12/17/2002US6495528 Antiinflammatory agents; inhibiting leukocyte recruitment and activation; agonists of adenosine 2a receptor
12/12/2002US20020187941 Pregabalin lactose conjugates
12/10/2002US6492534 Process and intermediate compounds for the preparation of pyrrolidines
12/05/2002US20020182625 Nucleotide sequence labelling compoumd four use as tool in genetic engineering
11/2002
11/20/2002CN1380342A Production method of phycocolloid oligosaccharide
11/19/2002US6482974 From tri-o-acetyl-d-erythro-4-pentulosonic acid esters
11/19/2002US6482973 From tri-o-acetyl-d-erythro-4-pentulosonic acid esters
11/19/2002US6482806 Product of heat treatment of uronic acid, food, drink, or drug including the product
11/14/2002WO2002090359A1 Glucuronide adduct as gaba ligand
11/13/2002EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/12/2002US6479650 Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same
11/06/2002EP0998280A4 Carbohydrate scaffold compounds and libraries
11/06/2002CN1093763C Anti-cancer substance suppressing cancerous metastasis
10/2002
10/31/2002WO2002086116A1 Sulfated fucoglucuronomannan
10/31/2002WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002US20020161221 Ether type lipid a 1-carboxylic acid analogs
10/31/2002US20020160411 Coupling with organometallic compound; emission light
10/24/2002WO2002083066A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/17/2002US20020150995 Methods for producing sialyloligosaccharides in a dairy source
10/16/2002EP0948509B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/10/2002WO2002078747A2 Pregabalin lactose conjugates
10/08/2002US6462197 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23